Cumulative incidence of clinical AF after HCT. (A) Cumulative incidence of clinical AF based on donor source. (B) Cumulative incidence of clinical AF in allo HCT recipients based on AI-ECG (low vs high predicted risk). (C) OS in the overall cohort based on AI-ECG prediction group. (D) Death without relapse in the overall cohort based on AI-ECG prediction.